Midi Health

About Midi Health

Midi Health occupies a unique and clinically important niche in the GLP-1 telehealth landscape: it is built specifically for women in menopause and perimenopause. Founded in 2020, Midi offers both compounded and brand-name GLP-1 medications (including Ozempic and Wegovy) starting from $127 per month, but what sets it apart is the integration of weight-management treatment with comprehensive hormone-aware clinical care.

The clinical model at Midi Health is among the most thorough we have evaluated. Patients receive care from providers who specialize in menopause medicine and understand how fluctuating estrogen, progesterone, and other hormones directly affect metabolism, weight distribution, and GLP-1 medication response. The platform includes lab testing, registered dietitian access, and ongoing clinical monitoring as part of its care plans. This is not a prescription mill; it is a multidisciplinary care team approach that treats weight as one component of a larger hormonal health picture.

Third-party validation is strong. Midi holds a 4.0-star rating across 1,220+ reviews on Trustpilot and a B rating with the Better Business Bureau. Patient reviews consistently highlight the quality of provider interactions, the depth of the initial evaluation, and the relief of finding a platform that understands menopause-related weight gain. Negative reviews occasionally mention wait times for initial appointments and insurance billing complexity.

Midi Health also accepts insurance, which is a meaningful differentiator. Many telehealth GLP-1 platforms operate on a cash-pay-only basis, but Midi’s insurance integration can dramatically reduce out-of-pocket costs for eligible patients. Combined with the option to prescribe either brand-name or compounded medications, Midi gives providers the flexibility to match treatment to each patient’s clinical needs and financial situation.

Our editorial team considers Midi Health a category leader for its target population. For women experiencing menopause or perimenopause who are struggling with weight changes, Midi offers a level of clinical specificity, hormonal expertise, and wraparound support that generic telehealth platforms simply cannot match. The combination of lab testing, dietitian access, hormone-aware prescribing, and insurance acceptance makes it one of the most comprehensive GLP-1 programs available.

At a Glance